Reboxetine (also known as PNU 155950E; Trade name: Edronax) is a selective norepinephrine reuptake inhibitor with Ki of 8.2 nM and antidepressant activity.

Salmeterol Xinafoate (GR-33343G, AHR-3929; AH-3923; Salmetedur, Serevent), the Xinafoate salt of Salmeterol, is a potent and long-acting β2-adrenergic receptor agonist with anti-inflammatory effects.

Atipamezole (Antisedan, MPV-1248) is a synthetic α2 adrenergic receptor antagonist with a Ki of 1.6 nM.

Higenamine hydrochloride is a novel and potent β-adrenoceptor partial agonist.

Indacaterol Maleate (formerly known as QAB149; QAB-149; Onbrez Breezhale; arcapta neohaler; Onbrez), the maleate salt of indacaterol, is an approved anti-COPD (chronic obstructive pulmonary disease) drug acting as an ultra-long-acting β-adrenoceptor agonist developed by Novartis.

Betaxolol HCl (Betoptima; Kerlone; Betoptic; Kerlon; SL-75212; ALO-1401-02; ALO140102), the hydrochloride salt of Betaxolol, is a potent beta-1/β1 adrenergic receptor antagonist with antihypertensive effects.

Lofexidine HCl (Lucemyra) is the hydrochloride salt of lofexidine which is an analog of Clonidine and an α2A adrenergic receptor agonist.

JP-1302 HCl, the hydrochloride salt form of JP1302, is a novel, selective, high affinity and potent α2C-adrenoceptor antagonist with a Ki of 28 nM and a Kb value (antagonist activity) of 16 nM.

Tizanidine HCl (AB 021 ; AN 021; DS 103-282; BRN-0618691; Sirdalud; Ternelin), the hydrochloride salt of tizanidine, is an alpha2/α2-adrenergic receptor agonist that has been approved for use mainly as a muscle relaxant to treat spasms, cramping, and tightness of muscles.

Labetalol (AH5158; Sch15719W) is a potent, competitive, dual antagonist for both selective alpha1-adrenergic and nonselective beta-adrenergic receptors with antihypertensive properties.